Stoke Therapeutics, Inc. (FRA:0GT)
Germany · Delayed Price · Currency is EUR 26.20
-0.60 (-2.24%)
At close: Dec 1, 2025
Stoke Therapeutics Market Cap
Stoke Therapeutics has a market cap or net worth of €1.52 billion as of December 1, 2025. Its market cap has increased by 118.70% in one year.
Market Cap
1.52B
Enterprise Value
1.24B
Revenue
175.26M
Ranking
n/a
PE Ratio
44.04
Stock Price
€26.20
Market Cap Chart
Since June 19, 2019, Stoke Therapeutics's market cap has increased from 717.17M to 1.52B, an increase of 112.30%. That is a compound annual growth rate of 12.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 1.48B | 161.98% |
| Dec 31, 2024 | 564.30M | 165.56% |
| Dec 29, 2023 | 212.49M | -37.60% |
| Dec 30, 2022 | 340.54M | -56.12% |
| Dec 31, 2021 | 776.08M | -57.70% |
| Dec 31, 2020 | 1.83B | 122.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |